Bilaketaren emaitzak - Judith Falloon

Findu emaitzak
  1. 1
    Cryptococcosis and Idiopathic CD4 Lymphocytopenia

    Cryptococcosis and Idiopathic CD4 Lymphocytopenia nork Dimitrios Zonios, Judith Falloon, Chiung Yu Huang, Doreen Chaitt, John E. Bennett

    Argitaratua 2007
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    The Effect of Garlic Supplements on the Pharmacokinetics of Saquinavir

    The Effect of Garlic Supplements on the Pharmacokinetics of Saquinavir nork Stephen C. Piscitelli, Aaron H. Burstein, Nada Welden, Keith Gallicano, Judith Falloon

    Argitaratua 2002
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Immunochemical evidence for a novel pertussis toxin substrate in human neutrophils.

    Immunochemical evidence for a novel pertussis toxin substrate in human neutrophils. nork Peter Gierschik, Judith Falloon, Graeme Milligan, Mark Pines, John I. Gallin, Allen M. Spiegel

    Argitaratua 1986
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7

    Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7 nork Angela Malaspina, Susan Moir, Doreen Chaitt, Catherine Rehm, Shyam Kottilil, Judith Falloon, Anthony S. Fauci

    Argitaratua 2006
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Immunogenicity and Safety of a Quadrivalent Live Attenuated Influenza Vaccine in Children

    Immunogenicity and Safety of a Quadrivalent Live Attenuated Influenza Vaccine in Children nork Stan L. Block, Judith Falloon, Jeffrey A. Hirschfield, Leonard R. Krilov, Filip Dubovsky, Tingting Yi, Robert B. Belshe

    Argitaratua 2012
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Endocrine and Metabolic Evaluation of Human Immunodeficiency Virus-Infected Patients with Evidence of Protease Inhibitor-Associated Lipodystrophy

    Endocrine and Metabolic Evaluation of Human Immunodeficiency Virus-Infected Patients with Evidence of Protease Inhibitor-Associated Lipodystrophy nork Jack A. Yanovski, Kirk D. Miller, Tomoshige Kino, Theodore C. Friedman, George P. Chrousos, Constantine Tsigos, Judith Falloon

    Argitaratua 1999
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites

    Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites nork Y M Zhang, Hiromi Imamichi, Tomozumi Imamichi, H. Clifford Lane, Judith Falloon, M. B. Vasudevachari, Norman P. Salzman

    Argitaratua 1997
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    An Adjuvanted, Postfusion F Protein–Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults

    An Adjuvanted, Postfusion F Protein–Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults nork Judith Falloon, Jing Yu, Mark T. Esser, Tonya Villafana, Yu Li, Filip Dubovsky, Therese Takas, Myron J. Levin, Ann R. Falsey

    Argitaratua 2017
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant

    A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant nork Judith Falloon, Fei Ji, Craig Curtis, Stephan Bart, Eric Sheldon, Diane Krieger, Filip Dubovsky, Stacie Lambert, Therese Takas, Tonya Villafana, Mark T. Esser

    Argitaratua 2016
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Vaccination in Humans Generates Broad T Cell Cytokine Responses

    Vaccination in Humans Generates Broad T Cell Cytokine Responses nork Stephen C. De Rosa, Fabien X. Lü, Joanne Yu, Stephen P. Perfetto, Judith Falloon, Susan E. Moser, Thomas G. Evans, Richard A. Koup, Christopher J. Miller, Mario Roederer

    Argitaratua 2004
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Subcutaneous Administration of Interleukin‐2 in Human Immunodeficiency Virus Type 1—Infected Persons

    Subcutaneous Administration of Interleukin‐2 in Human Immunodeficiency Virus Type 1—Infected Persons nork Richard T. Davey, Doreen Chaitt, Stephen C. Piscitelli, Mary Wells, Joseph A. Kovacs, Robert Walker, Judith Falloon, Michael A. Polis, Julia A. Metcalf, Henry Masur, G. Fyfe, H. Clifford Lane

    Argitaratua 1997
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine

    A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine nork Lauren A. Chang, Emily Phung, Michelle C. Crank, Kaitlyn M. Morabito, Tonya Villafana, Filip Dubovsky, Judith Falloon, Mark T. Esser, Bob C. Lin, Grace Chen, Barney S. Graham, Tracy J. Ruckwardt

    Argitaratua 2022
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial

    Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial nork Cory A. Perugino, Emma Culver, Arezou Khosroshahi, Wen Zhang, Emanuel Della‐Torre, Kazuichi Okazaki, Yoshiya Tanaka, Matthias Löhr, N. Schleinitz, Judith Falloon, Dewei She, Daniel Cimbora, John H. Stone

    Argitaratua 2023
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    JE-2147: A dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1

    JE-2147: A dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1 nork Kazuhisa Yoshimura, Ryohei Kato, Keisuke Yusa, Mark F. Kavlick, Victor Maroun, Aline Nguyen, Tsutomu Mimoto, Takamasa Ueno, Makoto Shintani, Judith Falloon, Henry Masur, Hideya Hayashi, John W. Erickson, Hiroaki Mitsuya

    Argitaratua 1999
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy

    Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy nork Sarah Palmer, Valerie F. Boltz, Frank Maldarelli, Mary F. Kearney, Elias K. Halvas, Diane Rock, Judith Falloon, Richard T. Davey, Robin Dewar, Julia A. Metcalf, John W. Mellors, John M. Coffin

    Argitaratua 2006
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Increases in CD4 T Lymphocytes with Intermittent Courses of Interleukin-2 in Patients with Human Immunodeficiency Virus Infection — A Preliminary Study

    Increases in CD4 T Lymphocytes with Intermittent Courses of Interleukin-2 in Patients with Human Immunodeficiency Virus Infection — A Preliminary Study nork Joseph A. Kovacs, Michael Baseler, Robin Dewar, Susan Vogel, Richard T. Davey, Judith Falloon, Michael A. Polis, Robert Walker, Randy Stevens, Norman P. Salzman, Julia A. Metcalf, Henry Masur, H. Clifford Lane

    Argitaratua 1995
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Controlled Trial of Interleukin-2 Infusions in Patients Infected with the Human Immunodeficiency Virus

    Controlled Trial of Interleukin-2 Infusions in Patients Infected with the Human Immunodeficiency Virus nork Joseph A. Kovacs, Susan Vogel, Jeffrey M. Albert, Judith Falloon, Richard T. Davey, Robert Walker, Michael A. Polis, Katherine Spooner, Julia A. Metcalf, Michael Baseler, G. Fyfe, H. C. Lane, Robin Dewar, Henry Masur

    Argitaratua 1996
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Multiple, Linked Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Treatment-Experienced Patients Are Missed by Standard Genotype Analysis

    Multiple, Linked Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Treatment-Experienced Patients Are Missed by Standard Genotype Analysis nork Sarah Palmer, Mary F. Kearney, Frank Maldarelli, Elias K. Halvas, Christian Bixby, Holly Bazmi, Diane Rock, Judith Falloon, Richard T. Davey, Robin Dewar, Julia A. Metcalf, Scott Hammer, John W. Mellors, John M. Coffin

    Argitaratua 2005
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors

    Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors nork Dimitrios Zonios, Judith Falloon, John E. Bennett, Pamela A. Shaw, Doreen Chaitt, Michael Baseler, Joseph W. Adelsberger, Julia A. Metcalf, Michael A. Polis, Stephen J. Kovacs, Joseph A. Kovacs, Richard T. Davey, H. Clifford Lane, Henry Masur, Irini Sereti

    Argitaratua 2008
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Comparison of Atovaquone (566C80) with Trimethoprim-Sulfamethoxazole to Treat Pneumocystis carinii Pneumonia in Patients with AIDS

    Comparison of Atovaquone (566C80) with Trimethoprim-Sulfamethoxazole to Treat Pneumocystis carinii Pneumonia in Patients with AIDS nork Walter Hughes, Gifford Leoung, Françoise Kramer, Samuel A. Bozzette, Sharon Safrin, Peter Frame, Nathan Clumeck, Henry Masur, Danny J. Lancaster, Charles K. Chan, James P. Lavelle, Joel Rosenstock, Judith Falloon, Judith Feinberg, Stephen W. LaFon, Michael J. Rogers, Fred R. Sattler

    Argitaratua 1993
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: